📷 Image: Et Now (via NewsData)
Business
Nikhil Kamath's Remark Sparks Debate on India's Pharmaceutical Profitability
🗓 20 Jun 2026, 02:32 AM
👁 1
Co-founder Nikhil Kamath's observation that India manufactures medicines but others profit has ignited discussions on innovation and value capture in the pharmaceutical sector.
A recent podcast featuring Zerodha co-founder Nikhil Kamath, Mankind Pharma Co-Founder Rajeev Juneja, and Dr. Reddy’s Co-CEO GV Prasad has brought to the forefront a critical question about India's pharmaceutical industry. Kamath's statement, "India makes medicines, someone else makes money," highlights a perceived paradox where the nation is a major global supplier of drugs but captures a smaller share of the profits.
The discussion delved into the complexities surrounding pharmaceutical production, innovation, patent regimes, and the value chain. It raised pertinent questions about how India can move beyond being a manufacturing hub to capture more significant economic benefits from its pharmaceutical prowess.
This conversation underscores the ongoing debate within the Indian business community and policy circles regarding the strategies needed to enhance value creation and profitability in key sectors like pharmaceuticals.
The discussion delved into the complexities surrounding pharmaceutical production, innovation, patent regimes, and the value chain. It raised pertinent questions about how India can move beyond being a manufacturing hub to capture more significant economic benefits from its pharmaceutical prowess.
This conversation underscores the ongoing debate within the Indian business community and policy circles regarding the strategies needed to enhance value creation and profitability in key sectors like pharmaceuticals.